China Likely to Make 5% Growth Its Bottom Line for 2022
China’s Economy Slows as Property Slump Deepens China is likely to set a floor for economic growth of 5% next year as it tries to balance a desire to rein Continue Reading
China’s Economy Slows as Property Slump Deepens China is likely to set a floor for economic growth of 5% next year as it tries to balance a desire to rein Continue Reading
China and Qatar have signed another long-term LNG contract, with Qatar set to send 1 million tons per annum to China starting in 2024 As a key U.S. ally and Continue Reading
The omicron variant appears to cause less severe disease than previous versions of the coronavirus, and the Pfizer vaccine seems to offer less defense against infection from it but still Continue Reading
The first large real-world study of how vaccines hold up against Omicron found that two shots of Pfizer Inc. and BioNTech SE’s Covid-19 vaccine lowered the risk of hospital admission by 70% for patients infected with the Continue Reading
Pfizer-BioNTech’s COVID-19 vaccine has been less effective in South Africa at keeping people infected with the virus out of hospital since the Omicron variant emerged last month, a real-world study Continue Reading
Executive Summary Absent any additional policies, our analysis in this alternative International Energy Outlook 2021 (IEO2021) case indicates that an increase in wages in China does not lead to a Continue Reading
Highlights Refining margins remain high ZPC raises throughput on the back of sufficient quotas Feedstock inventories fall for second month in a row China’s independent refiners in Shandong province lifted Continue Reading
China’s economy took a knock last month from an ongoing property market slump and sporadic Covid outbreaks, prompting economists to warn that recent easing measures may not be enough to Continue Reading
Highlights January-November throughput up 5% to 14.2 million b/d Throughput in 2022 to rise 512,000 b/d: Platts Analytics November crude output gains 2.7% on year to 3.99 mil b/d Chinese Continue Reading
Pfizer’s oral Covid treatment, Paxlovid, being produced in a laboratory in Freiburg, Germany. It includes a new pill, nirmatrelvir, as well as an existing medicine, ritonavir, that helps it remain Continue Reading